Skip to main content

News Archive

News Archive - School of Medicine

State’s Stem Cell Agency Awards Nearly $8 Million for New Leukemia Therapies

December 1, 2017

The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) unanimously approved yesterday two grants worth a total of almost $8 million to University of California San Diego School of Medicine researchers investigating novel stem cell-based treatments for acute myeloid leukemia or AML.

Vulnerability Identified for Subtypes of Glioblastoma

November 30, 2017

Glioblastoma, the most common and aggressive form of brain cancer, typically fails to respond to treatment or rapidly becomes drug resistant. In a paper published online in the journal Cancer Cell on November 30, University of California San Diego School of Medicine researchers identified a strategy that pinpoints a genetically distinct subpopulation of patients with glioblastoma that is particularly sensitive to drugs like cilengitide that target a cell adhesion receptor known as integrin αvβ3.

UC San Diego to Honor World AIDS Day Dec. 1 with Memorial Quilt Display

November 27, 2017

The University of California San Diego will recognize World AIDS Day on Friday, Dec. 1 to draw attention to the impact of HIV/AIDS has on the San Diego community, the nation and the globe. In honor of the international event, which was established in 1988, the campus will sponsor a number of free activities open to the public including a display of three sections of the AIDS Memorial Quilt, the largest ongoing arts project in the world.

Immunotherapy Research for Head and Neck Cancers Gets Boost from V Foundation Grant

November 27, 2017

A team of University of California San Diego School of Medicine and Moores Cancer Center researchers studying new drugs designed to break resistance to cancer immunotherapy has been awarded a V Foundation for Cancer Research translational grant of $600,000 over three years.

UC San Diego Health Named Medical Provider of the Year

November 20, 2017

The UC San Diego Health International Patient Program was recognized as the 2017 Medical Provider of the Year by the International Travel & Health Insurance Journal (ITIJ). ITIJ recognizes leading health systems from around the globe for their ability to provide comprehensive, culturally-sensitive care to patients from international destinations.

Six UC San Diego Professors Named 2017 AAAS Fellows

November 20, 2017

UC San Diego professors Michael Burkart, Catherine Constable, Richard Gallo, William Gerwick, Miroslav Krstic and Lorraine Pillus have been awarded the distinction of fellow by the American Association for the Advancement of Science (AAAS), the largest general science organization in the United States and publisher of the journal Science.

Cross Off That “To Do” List, Study Shows All Daily Activity Can Prolong Life

November 16, 2017

That “to do” list of chores and errands could actually provide a variety of health benefits, according to researchers at the University of California San Diego School of Medicine. The study, published in the Journal of the American Geriatrics Society, found women over age 65 who engaged in regular light physical activity had a reduction in the risk of mortality.

Renowned Surgeons Launch Acoustic Neuroma Program at UC San Diego Health

November 15, 2017

UC San Diego Health has expanded its treatment of rare brain tumors by launching a specialized program in the diagnosis and treatment of acoustic neuromas and complex skull base tumors. The new program will be led by Rick Friedman, MD, PhD, and Marc Schwartz, MD, internationally recognized authorities on the effective treatment of these challenging cases. Patients are currently being accepted into the program.

Epic Sharing within UC Health

November 14, 2017

In an unprecedented move, UC San Diego Health and UCI Health have formed a strategic partnership to increase operational efficiencies and decrease patient care costs by sharing a single electronic medical records (EMR) platform.

A New Strategy for Prevention of Liver Cancer Development

November 14, 2017

Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective treatments or drugs. However, an unexpected finding made by a team of University of California San Diego School of Medicine researchers sheds light on the development of a new strategy for prevention of liver cancer.
Category navigation with Social links